- Preclinical biotech, Foghorn Therapeutics (FHTX) has priced its initial public offering of 7.5M common shares at $16/share, at the midpoint of the expected range of $15-17. Gross proceeds estimated to be ~$120M.
- Trading commences today on Nasdaq.
- Offering is expected to close on October 27.
- Previously: Foghorn Therapeutics sets IPO terms to issue 7.5M shares (Oct. 19)
- https://seekingalpha.com/news/3625205-foghorn-therapeutics-prices-ipo-16
Friday, October 23, 2020
Foghorn Therapeutics prices IPO at $16
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.